HYPOACTIVE NEWSLETTER SPECIAL

WORDS FROM HYPOACTIVE RIDER GAVIN WRIGHT

 

Hi Everyone,

2018 HYPOACTIVE ANNUAL GENERAL MEETING

Date: 25th February

Time: 1200 pm

Venue: 4th Willliamstown Scout Hall, The Strand Williamstown

This is the annual chance for everyone to get together and talk about which direction HypoActive should or could take. For people to talk about events that we might get involved with or perhaps organise for the first time. It's a time for reflection and creative planning. A chance to think what has worked, what has not, and focus on doing more of what type 1's at all levels of ability get the most out of.

There will be the presentation of the financial report, which is of vital importance, as well as plenty of other general business. It won't be all drear, someone has promised to bring snacks and there'll be plenty of time to chat and swap ideas about what's truly important for HypoActive.

This meeting comes after the morning's Fun Run/Walk/Ride, so spirits will be high and everyone will be tuned in to big ideas about type 1 diabetes and exercise.

Come and join us!

 

Advertisement

Dexcom CGM: Distributed by AMSL Diabetes

The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM), with its Superior Accuracy (#1,2), is the only CGM System approved for you to dose without a fingerprick and can be shared directly onto a compatible Android or Apple smart device. Dexcom is now on the CGM Subsidy Initiative for eligible patients under 21, visit the NDSS website for details. For more information on the Dexcom range please visit the AMSL Dexcom G5 Mobile webpage or contact AMSL Diabetes on 1300 851 056.

#1. Bailey, Chang, Christiansen Clinical Accuracy of a Continuous Glucose Monitoring System with an Advanced Algorithm J Diabetes Sc Tech 2015 Vol 9(2) 209-214.  #2. Laffel Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus – Results from Two Studies Diabetes Technology & Therapeutics Volume 18, Supplement 2, 2016.

 

Advertisement

FreeStyle Libre Real World Results
Real-world data from more than 50,000 people show that higher rates of scanning with the FreeStyle Libre system were found to be strongly associated with improved glucose control. MORE SCANNING: Users checked their glucose levels an average of 16.3 scans per day. As scan rates increased, the following trends were observed: IMPROVED HbA1c: Average glucose level decreased as scan rate increased with estimated HbA1c decreasing from 8.0 to 6.7 percent. REDUCTION IN HYPOGLYCAEMIA: Time spent below glucose levels of 3.9, 3.1 and 2.5 mmol/L decreased by 15 percent, 40 percent and 49 percent. REDUCTION IN HYPERGLYCAEMIA: Time above 10 mmol/L decreased from 10.4 to 5.7 hours per day. INCREASED TIME IN RANGE: Time in glucose range (3.9-10 mmol/L) increased from 12.0 to 16.8 hours per day. Order your FreeStyle Libre today at www.FreeStyleLibre.com.au!

The FreeStyle Libre Flash Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (aged 18 and older) with insulin dependent diabetes mellitus. Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. † Data on file. Dunn T, Xu Y, Hayter G; Evidence of a Strong Association Between Frequency of Flash Glucose Monitoring and Glucose Control Measures During Real-World Usage. All work was funded by and the authors are employees of Abbott Diabetes Care. Ask your healthcare professional how a FreeStyle glucose meter may assist you. Always read the label and use only as directed. FreeStyle and related brand marks are trademarks of Abbott Diabetes Care Inc. in various jurisdictions.